Transplant Clinical Trials in Dallas, Texas
24 recruitingDallas, Texas
Showing 1–20 of 24 trials
Recruiting
Phase 2
Tocilizumab in Lung Transplantation
Lung Transplant
National Institute of Allergy and Infectious Diseases (NIAID)350 enrolled21 locationsNCT06033196
Recruiting
Diagnostic and Therapeutic Applications of Microarrays in Heart Transplantation
Cardiac Transplant Disorder
University of Alberta900 enrolled13 locationsNCT02670408
Recruiting
Trifecta-Lung cfDNA-MMDx Study
Lung transplantation
University of Alberta600 enrolled19 locationsNCT05837663
Recruiting
Trifecta-Heart cfDNA-MMDx Study
heart transplant rejection
University of Alberta300 enrolled12 locationsNCT04707872
Recruiting
Phase 3
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy
Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD)Solid Organ Transplant ComplicationsLymphoproliferative Disorders+2 more
Pierre Fabre Medicament115 enrolled71 locationsNCT03394365
Recruiting
Phase 2
Expanding Liver Transplant Immunosuppression Minimization Via Everolimus
Liver Transplant
National Institute of Allergy and Infectious Diseases (NIAID)340 enrolled8 locationsNCT06280950
Recruiting
Phase 3
Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Ravulizumab Administered Intravenously in Adult Participants at High Risk of Delayed Graft Function After Kidney Transplantation
Kidney TransplantDelayed Graft FunctionDGF
Alexion Pharmaceuticals, Inc.450 enrolled130 locationsNCT06830798
Recruiting
Phase 2
Phase 2 Study of ALXN2030 in Patients With Antibody-Mediated Rejection After Kidney Transplantation
Kidney TransplantationAMRAntibody-mediated Rejection+1 more
Alexion Pharmaceuticals, Inc.45 enrolled55 locationsNCT06744647
Recruiting
Not Applicable
XVIVO Heart Box (XHB) With Supplemented XVIVO Heart Solution (SXHS) Continued Access Protocol (CAP)
Heart FailureHeart TransplantTransplant; Failure, Heart
XVIVO Perfusion60 enrolled14 locationsNCT06895070
Recruiting
Phase 4
Sparsentan in Posttransplant Immunoglobulin A Nephropathy or Focal Segmental Glomerulosclerosis
Kidney TransplantFocal Segmental GlomerulosclerosisProteinuria+1 more
Travere Therapeutics, Inc.20 enrolled9 locationsNCT07219121
Recruiting
Phase 2
A Study to Evaluate Tabelecleucel in Participants With Epstein Barr Virus (EBV) Associated Diseases
LeiomyosarcomaSolid Organ Transplant ComplicationsLymphoproliferative Disorders+8 more
Pierre Fabre Medicament190 enrolled40 locationsNCT04554914
Recruiting
Cardiopulmonary Stress Testing (CPET) AlloSure Study
Heart FailureTransplant; Failure, Heart
Baylor Research Institute27 enrolled1 locationNCT04656080
Recruiting
The Hepatitis C Transplant Collaborative
Transplant; Failure, HeartHepatitis C
Baylor Research Institute500 enrolled1 locationNCT04493385
Recruiting
Not Applicable
Enhancing Heart Allograft Function With the OCS Heart System Trial
Heart Transplant
TransMedics655 enrolled8 locationsNCT07145515
Recruiting
Validation of Donor-Derived Cell-Free DNA (Dd-cfDNA) for Kidney Transplant Monitoring
Kidney Transplant RejectionCell Free DNA
Insight Molecular Diagnostics125 enrolled10 locationsNCT07060716
Recruiting
US National OCS Heart Perfusion (OHP) Registry
Heart Transplant
TransMedics100,000 enrolled37 locationsNCT05915299
Recruiting
US National TOP Registry
Lung Transplant
TransMedics10,000 enrolled7 locationsNCT06513091
Recruiting
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
Solid TumorLeukemiaHematopoietic Cell Transplantation Recipient
Children's Oncology Group5,000 enrolled164 locationsNCT00736749
Recruiting
Donor Outcomes Following Hand-Assisted and Robotic Living Donor Nephrectomy: a Retrospective Review
Kidney DiseasesTransplant
Methodist Health System240 enrolled1 locationNCT04182607
Recruiting
US National OCS Liver Perfusion (OLP) Registry
Liver Transplant
TransMedics100,000 enrolled22 locationsNCT05940857